S 2513 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill appears to deal with fees that companies pay to the government related to over-the-counter (OTC) monograph drugs, which are common non-prescription medicines like pain relievers or cold medicines. It seems to focus on making the process for collecting or using those fees more transparent and open to the public. No official summary is available for this bill.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.